TDOC Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
605.1M
-0.3%
606.9M
-1.1%
613.8M
-4.4%
642.3M
+2.5%
626.4M
Cost of Revenue
190.3M
-0.3%
190.8M
-3.4%
197.5M
+0.2%
197.0M
+5.3%
187.2M
Gross Profit
414.8M
-0.3%
416.1M
-0.1%
416.3M
-6.5%
445.2M
+1.4%
439.3M
Operating Expenses
442.9M
-1.9%
451.5M
-5.6%
478.1M
-0.7%
481.2M
-2.0%
491.2M
R&D
65.5M
+4.3%
62.9M
-7.4%
67.9M
-5.2%
71.6M
+6.0%
67.6M
SG&A
281.0M
-5.3%
296.8M
-2.6%
304.9M
-0.3%
305.7M
-4.1%
318.8M
Operating Income
-28099000
+20.6%
-35402000
+42.7%
-61768000
-71.6%
-35997000
+30.7%
-51962000
EBITDA
68.3M
+21.1%
56.4M
+29.5%
43.6M
-35.8%
67.9M
+28.3%
52.9M
Net Income
-26934000
+30.8%
-38908000
+39.1%
-63837000
-153.9%
-25143000
+49.2%
-49507000
EPS (Basic)
$-0.15
+28.6%
$-0.21
+41.7%
$-0.36
-157.1%
$-0.14
+50.0%
$-0.28
EPS (Diluted)
$-0.15
+28.6%
$-0.21
+41.7%
$-0.36
-157.1%
$-0.14
+50.0%
$-0.28
Shares (Diluted)
181.9M
+0.5%
181.0M
+1.1%
179.1M
+0.7%
177.9M
+0.5%
176.9M
Teladoc Health (TDOC) — Financials